| 12234221 |
Pyridine carboxamide compounds for inhibiting NAV1.8 |
Michael S. Poslusney, Glen Ernst, Yifang Huang |
2025-02-25 |
|
| 12049467 |
Substituted benzopyrazolo[1,5-a][1,4]diazepines as GABA positive allosteric modulators |
Yifang Huang, Pankaj J. Pasricha, Ingrid Buchler, Michael S. Poslusney |
2024-07-30 |
$44,715,000 |
| 11993581 |
Pyridazine compounds for inhibiting Nav1.8 |
Michael S. Poslusney, Glen Ernst |
2024-05-28 |
|
| 11649473 |
Enzymatic modification of oil |
Jaroslav A. Kralovec, Weijie Wang |
2023-05-16 |
|
| 11136322 |
Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system |
Pankaj J. Pasricha, Yifang Huang |
2021-10-05 |
|
| 11001581 |
Compounds which inhibit RNA polymerase, compositions including such compounds, and their use |
Marikki Laiho, Laureen Colis, Glen Ernst, Sara Sanders |
2021-05-11 |
|
| 10934283 |
COMT inhibiting methods and compositions |
Glen Ernst, Dominique Swinnen, Florian Montel, Sabine Defays, Yifang Huang +2 more |
2021-03-02 |
|
| 10844070 |
Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system |
Pankaj J. Pasricha, Yifang Huang |
2020-11-24 |
|
| 10479790 |
COMT inhibiting methods and compositions |
Glen Ernst, Yifang Huang, Ingrid Buchler, Daniel Weinberger |
2019-11-19 |
|
| 10415065 |
Enzymatic modification of oil |
Jaroslav A. Kralovec, Weijie Wang |
2019-09-17 |
|
| 10266534 |
Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system |
Pankaj J. Pasricha, Yifang Huang |
2019-04-23 |
|
| 10035799 |
COMT inhibiting methods and compositions |
Glen Ernst, Yifang Huang, Ingrid Buchler, Daniel Weinberger |
2018-07-31 |
|
| 9951057 |
COMT inhibiting methods and compositions |
Glen Ernst, Yifang Huang, Ingrid Buchler, Daniel Weinberger |
2018-04-24 |
|
| 9885068 |
Enzymatic modification of oil |
Jaroslav A. Kralovec, Weijie Wang |
2018-02-06 |
|
| 9399651 |
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders |
Scott Wolkenberg, Michael S. Poslusney, Scott T. Harrison, Wesley B. Trotter, James Mulhearn +6 more |
2016-07-26 |
$145,345,000 |
| 9309199 |
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders |
Scott Wolkenberg, Scott T. Harrison, B. Wesley Trotter, Kausik K. Nanda, Peter J. Manley +1 more |
2016-04-12 |
$97,149,000 |
| 9266881 |
Triazolopyridinone PDE10 inhibitors |
Christopher D. Cox, Mark B. Nolt, William D. Shipe |
2016-02-23 |
$104,084,000 |
| 9260413 |
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders |
Scott Wolkenberg, Scott T. Harrison, Zhijan Zhao, Jeffrey Melamed, Nathan R. Kett +1 more |
2016-02-16 |
$70,528,000 |
| 9023616 |
Oil producing microbes and method of modification thereof |
Helia Radianingtyas, Adam M. Burja |
2015-05-05 |
|
| 9024032 |
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders |
Scott Wolkenberg, Michael S. Poslusney, Scott T. Harrison, B. Wesley Trotter, James Mulhearn +6 more |
2015-05-05 |
$66,112,000 |
| 8987310 |
Heterocycle amide T-type calcium channel antagonists |
Kelly-Ann S. Schlegel, Yoheng Shu, Zhi-Qiang Yang |
2015-03-24 |
$65,013,000 |
| 8969364 |
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders |
Scott Wolkenberg, Scott T. Harrison, Zhijian Zhao, Jeffrey Melamed, Nathan R. Kett +1 more |
2015-03-03 |
$90,475,000 |
| 8637513 |
Heterocycle phenyl amide T-type calcium channel antagonists |
Paul J. Coleman, Thomas S. Reger, Kelly-Ann S. Schlegel, Youheng Shu, Zhi-Qiang Yang |
2014-01-28 |
$54,750,000 |
| 8530483 |
Substituted azabenzoxazoles |
Scott T. Harrison, James Mulhearn, Cyrille Sur, David L. Williams, Scott Wolkenberg +1 more |
2013-09-10 |
$90,068,000 |
| 8501773 |
4-fluoro-piperidine T-type calcium channel antagonists |
Craig W. Lindsley, William D. Shipe, Zhiqiang Yang, David Wisnoski |
2013-08-06 |
$72,172,000 |
